Using Clostridium Butyricum Miyairisan to treat symptoms of Parkinson's Disease
The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease
This study is testing if a treatment called Clostridium Butyricum Miyairisan can help improve both movement and daily life for people with Parkinson's disease.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 20 Years to 90 Years |
| Sex | All |
| Sponsor | Kaohsiung Medical University Chung-Ho Memorial Hospital Academic / other |
| Locations | 1 site (Kaohsiung City) |
| Trial ID | NCT06548256 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of Clostridium Butyricum Miyairi in alleviating both motor and non-motor symptoms in patients with Parkinson's disease. It is an open-label, single-center, non-randomized trial where participants will receive the treatment and undergo assessments to measure outcomes. The study aims to gather data on how this intervention impacts the quality of life for those affected by Parkinson's disease.
Who should consider this trial
Good fit: Ideal candidates are adults over 20 years old who have been diagnosed with Parkinson's disease.
Not a fit: Patients with Parkinson's disease dementia or lactose intolerance may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the management of symptoms in Parkinson's disease patients.
How similar studies have performed: While this approach is relatively novel, similar studies exploring gut microbiota and neurological conditions have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female over 20 years old, diagnosed with Parkinson's disease. Exclusion Criteria: * People with Parkinson's disease Dementia, or Lactose Intolerance
Where this trial is running
Kaohsiung City
- Kaohsiung Medical Univeristy Hospital — Kaohsiung City, Taiwan (Recruiting)
Study contacts
- Study coordinator: Yang-Pei Chang, M.D.; MSc.
- Email: cyp905@gmail.com
- Phone: 886-7-2911101
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.